We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-15.8%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$537M
AUM Growth
-$133M
Cap. Flow
-$47.6M
Cap. Flow %
-8.86%
Top 10 Hldgs %
11.25%
Holding
1,208
New
454
Increased
145
Reduced
142
Closed
463

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$10.5M
2
TFC icon
Truist Financial
TFC
+$8.46M
3
QCOM icon
Qualcomm
QCOM
+$8.04M
4
WBA
Walgreens Boots Alliance
WBA
+$4.59M
5
EOG icon
EOG Resources
EOG
+$4.52M

Sector Composition

Rank Sector Weight
1 Technology 20.77%
2 Healthcare 13.14%
3 Consumer Discretionary 12.35%
4 Industrials 11.65%
5 Financials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GFL icon
276
GFL Environmental
GFL
$14.1B
$603K 0.11%
+23,379
New +$693K
C icon
277
Citigroup
C
$223B
$602K 0.11%
13,100
+6,600
+102% +$330K
VRSN icon
278
VeriSign
VRSN
$24.8B
$602K 0.11%
3,600
-1,896
-34% -$348K
CE icon
279
Celanese
CE
$4.87B
$600K 0.11%
+5,100
New +$732K
MAC icon
280
Macerich
MAC
$7.41B
$600K 0.11%
68,900
+45,100
+189% +$545K
ALKS icon
281
Alkermes
ALKS
$8.79B
$599K 0.11%
+20,100
New +$577K
SLAB icon
282
Silicon Laboratories
SLAB
$7.17B
$599K 0.11%
+4,275
New +$598K
PTC icon
283
PTC
PTC
$14.5B
$598K 0.11%
+5,621
New +$607K
CINF icon
284
Cincinnati Financial
CINF
$28.5B
$592K 0.11%
+4,979
New +$632K
ACAD icon
285
Acadia Pharmaceuticals
ACAD
$4.35B
$587K 0.11%
+41,696
New +$778K
BAX icon
286
Baxter International
BAX
$12.1B
$585K 0.11%
+9,106
New +$661K
CALY
287
Callaway Golf Company
CALY
$3.28B
$584K 0.11%
+28,646
New +$616K
SNOW icon
288
Snowflake
SNOW
$94.6B
$584K 0.11%
4,200
+2,900
+223% +$459K
AGR
289
DELISTED
Avangrid, Inc.
AGR
$583K 0.11%
+12,633
New +$586K
SAVE
290
DELISTED
Spirit Airlines, Inc.
SAVE
$583K 0.11%
24,449
-21,897
-47% -$486K
THC icon
291
Tenet Healthcare
THC
$21B
$578K 0.11%
+11,000
New +$766K
GNTX icon
292
Gentex
GNTX
$4.88B
$576K 0.11%
20,586
+9,900
+93% +$288K
CTXS
293
DELISTED
Citrix Systems Inc
CTXS
$573K 0.11%
+5,893
New +$587K
EVR icon
294
Evercore
EVR
$13.2B
$571K 0.11%
6,101
-2,900
-32% -$309K
BXP icon
295
Boston Properties
BXP
$11B
$565K 0.11%
+6,345
New +$702K
GOOS
296
Canada Goose Holdings
GOOS
$891M
$563K 0.1%
+31,270
New +$660K
HOMB icon
297
Home BancShares
HOMB
$6.21B
$562K 0.1%
+27,053
New +$585K
LUV icon
298
Southwest Airlines
LUV
$22.2B
$560K 0.1%
+15,500
New +$666K
NFG icon
299
National Fuel Gas
NFG
$7.67B
$556K 0.1%
+8,418
New +$590K
CPRT icon
300
Copart
CPRT
$27.6B
$554K 0.1%
+20,400
New +$581K

Similar funds

Bayesian Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bayesian Capital Management held 1,208 positions worth $537M, down 20% from $670M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bayesian Capital Management withdrew a net $47.6M in Q2 2022, closing 463 positions and reducing 142 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $35.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bayesian Capital Management opened a new position in T-Mobile US worth $10.8M.

  • Bayesian Capital Management's largest Q2 2022 buy was T-Mobile US: 80,110 shares worth $10.8M.
  • Bayesian Capital Management added most to iShares Russell 2000 ETF in Q2 2022, an estimated $4.26M increase.
  • Bayesian Capital Management's biggest Q2 2022 reduction was Verizon, cutting an estimated $4.51M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $35.6M.
  • Bayesian Capital Management's ten largest holdings make up 11% of its $537M portfolio in Q2 2022.
  • Bayesian Capital Management opened 454 new positions and closed 463 in Q2 2022.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $537M.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.